Cardiovascular Systems, Inc. (CSII): Price and Financial Metrics


Cardiovascular Systems, Inc. (CSII): $13.60

-1.12 (-7.61%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CSII POWR Grades

  • CSII scores best on the Value dimension, with a Value rank ahead of 74.62% of US stocks.
  • The strongest trend for CSII is in Growth, which has been heading up over the past 177 days.
  • CSII ranks lowest in Momentum; there it ranks in the 17th percentile.

CSII Stock Summary

  • For CSII, its debt to operating expenses ratio is greater than that reported by just 15.27% of US equities we're observing.
  • In terms of twelve month growth in earnings before interest and taxes, CARDIOVASCULAR SYSTEMS INC is reporting a growth rate of 106.54%; that's higher than 86.82% of US stocks.
  • Revenue growth over the past 12 months for CARDIOVASCULAR SYSTEMS INC comes in at -7.51%, a number that bests merely 15.56% of the US stocks we're tracking.
  • If you're looking for stocks that are quantitatively similar to CARDIOVASCULAR SYSTEMS INC, a group of peers worth examining would be SGHT, SNES, ISR, XGN, and CVRX.
  • Visit CSII's SEC page to see the company's official filings. To visit the company's web site, go to www.csi360.com.

CSII Valuation Summary

  • In comparison to the median Healthcare stock, CSII's price/earnings ratio is 166.06% lower, now standing at -14.6.
  • CSII's price/earnings ratio has moved down 8.6 over the prior 202 months.

Below are key valuation metrics over time for CSII.

Stock Date P/S P/B P/E EV/EBIT
CSII 2023-01-30 2.4 2.4 -14.6 -14.2
CSII 2023-01-27 2.4 2.3 -14.4 -13.9
CSII 2023-01-26 2.4 2.3 -14.5 -14.1
CSII 2023-01-25 2.4 2.3 -14.6 -14.1
CSII 2023-01-24 2.4 2.4 -14.6 -14.2
CSII 2023-01-23 2.4 2.3 -14.6 -14.1

CSII Growth Metrics

    The 5 year net cashflow from operations growth rate now stands at -70.41%.
  • Its 4 year price growth rate is now at 28.95%.
  • Its 4 year revenue growth rate is now at 30.82%.
CSII's revenue has moved down $21,448,000 over the prior 15 months.

The table below shows CSII's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 237.525 -27.14 -38.946
2022-06-30 236.222 -24.272 -36.933
2022-03-31 244.713 -12.907 -32.528
2021-12-31 251.765 -12.732 -28.874
2021-09-30 256.799 -9.506 -19.963
2021-06-30 258.973 -0.884 -13.421

CSII's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CSII has a Quality Grade of B, ranking ahead of 75.78% of graded US stocks.
  • CSII's asset turnover comes in at 0.745 -- ranking 42nd of 186 Medical Equipment stocks.
  • NVRO, KRMD, and CRY are the stocks whose asset turnover ratios are most correlated with CSII.

The table below shows CSII's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.745 0.764 -0.051
2021-03-31 0.670 0.780 -0.109
2020-12-31 0.731 0.786 -0.110
2020-09-30 0.827 0.791 -0.161
2020-06-30 0.945 0.794 -0.232
2020-03-31 1.192 0.801 -0.078

CSII Price Target

For more insight on analysts targets of CSII, see our CSII price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $45.88 Average Broker Recommendation 1.65 (Moderate Buy)

CSII Stock Price Chart Interactive Chart >

Price chart for CSII

CSII Price/Volume Stats

Current price $13.60 52-week high $23.47
Prev. close $14.72 52-week low $12.26
Day low $13.52 Volume 350,600
Day high $14.70 Avg. volume 239,613
50-day MA $13.82 Dividend yield N/A
200-day MA $14.75 Market Cap 569.60M

Cardiovascular Systems, Inc. (CSII) Company Bio


Cardiovascular Systems develops, manufactures, and markets devices for the treatment of vascular diseases, targeting a range of plaque types in leg arteries above and below the knee. The company was founded in 1989 and is based in St. Paul, Minnesota.


CSII Latest News Stream


Event/Time News Detail
Loading, please wait...

CSII Latest Social Stream


Loading social stream, please wait...

View Full CSII Social Stream

Latest CSII News From Around the Web

Below are the latest news stories about CARDIOVASCULAR SYSTEMS INC that investors may wish to consider to help them evaluate CSII as an investment opportunity.

Cardiovascular Systems (CSII) Global Sales Up, Margin Woe Stays

Cardiovascular Systems (CSII) international revenues are showing strong growth in each of the key markets, including Japan, Europe, Asia Pacific and Canada.

Yahoo | January 19, 2023

Cardiovascular Systems, Inc. to Host Earnings Conference Call on February 9, 2023

ST. PAUL, Minn., January 19, 2023--CARDIOVASCULAR SYSTEMS, INC. TO HOST EARNINGS CONFERENCE CALL ON FEBRUARY 9, 2023

Yahoo | January 19, 2023

Cardiovascular Systems, Inc. Enrolls First Patient in Japan for Kaizen Clinical Study

ST. PAUL, Minn., January 11, 2023--CARDIOVASCULAR SYSTEMS, INC. ENROLLS FIRST PATIENT IN JAPAN FOR KAIZEN CLINICAL STUDY

Yahoo | January 11, 2023

Cardiovascular Systems, Inc. Announces FDA 510(k) Submission of Innova Vascular, Inc.’s Thrombectomy System

ST. PAUL, Minn., January 04, 2023--Cardiovascular Systems, Inc. Announces FDA 510(k) Submission of Innova Vascular, Inc.’s Thrombectomy System

Yahoo | January 4, 2023

The past three years for Cardiovascular Systems (NASDAQ:CSII) investors has not been profitable

While it may not be enough for some shareholders, we think it is good to see the Cardiovascular Systems, Inc...

Yahoo | December 20, 2022

Read More 'CSII' Stories Here

CSII Price Returns

1-mo -5.09%
3-mo -1.09%
6-mo -16.51%
1-year -26.21%
3-year -66.69%
5-year -40.87%
YTD -0.15%
2022 -27.48%
2021 -57.08%
2020 -9.94%
2019 70.55%
2018 20.26%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8791 seconds.